High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure

High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of β-Blockers to Reduce Their Elevated Risk.

Natriuretic Peptide Type-B Gene

The structure of the mouse natriuretic peptide type-B (BNP) gene was determined by isolating and sequencing genomic clones. The mouse BNP gene was structurally similar to other natriuretic peptide genes and comprised three exons and two introns. Expression of the mouse BNP gene was found only in cardiac tissue as determined by ribonuclease protection analyses. Initiation of transcription was 31...

B-type natriuretic peptide in high-risk major surgery patients.

criterion for assessment of observed variability. Given an inherent variability of +20% for each method under comparison, the combined variability (i.e. limits of agreement) should not exceed +30% of the mean SVV. Applying these strict criteria to the data, agreement of methods studied by the authors was unacceptable. Secondly, the authors compared SV derived from different methods at specified...

Biomarker for Cardiomyopathy-B-Type Natriuretic Peptide

Cardiomyopathy is cardiac condition in which the normal muscular function of the myocardium has been altered by a variety of etiologies. Atherosclerotic coronary artery disease is the most common cause of cardiomyopathy in North America and Europe. Idiopathic cardiomyopathy is the second most common cause, although this may partially include undiagnosed etiologies such as viral infection, drug ...

B-type natriuretic peptide: where are we?

who presented at an A&E department with acute dyspnea and showed that a BNP > 100 pg/mL had a sensitivity of 90% and a specificity of 70% in differentiating dyspnea of cardiac origin from that of other causes. The diagnostic accuracy rose from 74 to 81% when BNP levels were added to clinical criteria7. The diagnostic power of BNP was greater than that of either the Framingham criteria or the Na...